Litigation Details for Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries Limited (D. Del. 2016)
✉ Email this page to a colleague
Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries Limited (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-10-27 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Defendant | Referred To | |
| Patents | 7,211,267; 7,232,572; 7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; 8,603,506; 8,709,478; 9,241,946 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries Limited (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-11-21 | 78 | families of patents: the Ashley patents, U.S. Patent Nos. 7,211,267 (the "'267 patent");…#39;946 patent") (collectively, the "Ashley patents"), and the Chang patents, U.S. …. Patent Nos. 7,749,532 (the "'532 patent"); 8,206,740 (the "'740 patent")…#39;267 patent, claims 1 and 20 of the '572 patent, claims 1 and 8 of the '506 patent, and claims…#39;740 patent; claims 2 and 19 of the '405 patent; and claims 2 and 19 of the '406 patent. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
